EPEmanuela Postiglione

Emanuela Postiglione

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emanuela Postiglione has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sex effect on disease characteristics in patients with narcolepsy type 1

    by Lucie Barateau, Fabio Pizza, Emanuela Postiglione, Sofiene Chenini, Francesco Biscarini, Francesca Ingravallo, Séverine Béziat, Isabelle Jaussent, Giuseppe Plazzi, Yves Dauvilliers

    Study objectives: Narcolepsy type 1 (NT1) is a rare sleep disorder caused by orexin/hypocretin (Hcrt-1) deficiency, equally prevalent in women and men. Sex differences have been reported in animal models, particularly regarding cataplexy. Whether these differences can be transposed to humans remains unclear. We studied the sex effect on the characteristics of the disease in a large population of patients with NT1 in drug-free conditions. Methods: Six hundred and seventy-three drug-free NT1 patients (221 children under the age of 18 years, 297 women/girls), all Hcrt-1-deficient, were evaluated at baseline in two European Experts Centers. Clinical characteristics, cerebrospinal fluid Hcrt-1 levels, nocturnal polysomnography (PSG), and multiple sleep latency tests (MSLT) were compared between sexes. Results were adjusted for several potential confounding factors (center, age, body mass index, drug status). Results: A younger age of NT1 onset was more frequent in men/boys than in women/girls. In adults, women had a lower body mass index, slept longer, with a higher sleep efficiency, more stage 3, less wakefulness after sleep onset, and sleep apnea. In children, girls reported more hallucinations, disrupted nocturnal sleep, and higher Narcolepsy Severity Scale scores, without differences for PSG/MSLT features. Conclusions: Few differences were observed between men/boys and women/girls with NT1 on age at onset, nocturnal sleep, and hallucinations, without differences related to the severity of daytime sleepiness and cataplexy. Future longitudinal studies could investigate possible sex-specificities such as hormonal status conditions, treatment response, and disease course.


  • Narcolepsy with intermediate cerebrospinal level of hypocretin-1

    by Emanuela Postiglione, Lucie Barateau, Fabio Pizza, Régis Lopez, Elena Antelmi, Anna-Laura Rassu, Stefano Vandi, Sofiene Chenini, Emmanuel Mignot, Yves Dauvilliers, et al.

    Study Objectives: To describe the phenotype of narcolepsy with intermediate cerebrospinal fluid hypocretin-1 levels (CSF hcrt-1).Methods: From 1600 consecutive patients with narcolepsy from Bologna and Montpellier sleep centers, we selected patients with intermediate CSF hcrt-1 levels (110–200 pg/mL). Clinical, neurophysiological, and biological data were contrasted for the presence of cataplexy, human leukocyte haplotype (HLA)-DQB1*06:02, and median CSF hcrt-1 levels (149.34 pg/mL).Results: Forty-five (55% males, aged 35 ± 17 years) patients (2.8% of all cases) were included. Thirty-three (73%) were HLA-DQB1*06:02, 29 (64%) reported cataplexy (21, 72.4% with typical features), and 5 (11%) had presumed secondary etiology. Cataplexy was associated with other core narcolepsy symptoms, increased sleep onset rapid eye movement periods, and nocturnal sleep disruption. Cataplexy and irrepressible daytime sleep were more frequent in HLA-DQB1*06:02 positive patients. Lower CSF hcrt-1 levels were associated with hallucinations.Conclusions: Narcolepsy with intermediate CSF hcrt-1 level is a rare condition with heterogeneous phenotype. HLA-DQB1*06:02 and lower CSF hcrt-1 were associated with typical narcolepsy features, calling for future research to distinguish incomplete from secondary narcolepsy forms.


  • Open Access

    Impact of COVID‐19 pandemic lockdown on narcolepsy type 1 management

    by Emanuela Postiglione, Fabio Pizza, Francesca Ingravallo, Luca Vignatelli, Marco Filardi, Anastasia Mangiaruga, Elena Antelmi, Monica Moresco, Claudia Oriolo, Uberto Pagotto, et al.

    Study Objectives: Narcolepsy type 1 (NT1) is a chronic rare hypersomnia of central origin requiring a combination of behavioral and pharmacological treatments. During the coronavirus disease 2019 (COVID‐19) pandemic, in Italy the population was forced into a lockdown. With this study, we aimed to describe the lockdown impact on NT1 symptom management, according to different patients' working schedule.Methods: In the period between 10 April and 15 May 2020, we performed routine follow‐up visits by telephone (as recommended during the COVID‐19 emergency) to 50 patients >18 years old (40% males) under stable long‐term treatment. We divided patients into three groups: unchanged working schedule, forced working/studying at home, and those who lost their job (“lost occupation”). Current sleep–wake habit and symptom severity were compared with prelockdown assessment (six months before) in the three patient groups.Results: At assessment, 20, 22, and eight patients belonged to the unchanged, working/studying at home, and lost occupation groups, respectively. While in the lost occupation group, there were no significant differences compared with prepandemic assessment, the patients with unchanged schedules reported more nocturnal awakenings, and NT1 patients working/studying at home showed an extension of nocturnal sleep time, more frequent daytime napping, improvement of daytime sleepiness, and a significant increase in their body mass index. Sleep‐related paralysis/hallucinations, automatic behaviors, cataplexy, and disturbed nocturnal sleep did not differ.Conclusions: Narcolepsy type 1 patients working/studying at home intensified behavioral interventions (increased nocturnal sleep time and daytime napping) and ameliorated daytime sleepiness despite presenting with a slight, but significant, increase of weight.